|Weiss: Protection by Neutralizing Antibodies
|Protein & peptide vaccines
|Study Start Date:
|Study Made Public:
Further investigation of the mixing of HIV env antigens, and the effect of Toll-like receptor (TLR) stimulating adjuvants.
CAVD 312 is a preclinical rabbit study assessing combined HIV strains for immunizing potential in different adjuvants, in comparison with each strain alone. Modest neutralization was found with Freunds adjuvant in comparison to TLR agonists.
Sign in to see full information about this study and to download study data.